Detalles de la búsqueda
1.
Cancer Type and Histology Influence Cutaneous Immunotherapy Toxicities: A Multi-Institutional Cohort Study.
Br J Dermatol
; 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366637
2.
A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.
Oncologist
; 28(12): 1094-1099, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37844295
3.
Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study.
Oncologist
; 28(6): e379-e390, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36821637
4.
Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis.
Clin Gastroenterol Hepatol
; 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38142835
5.
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.
J Am Acad Dermatol
; 88(5): 1024-1032, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736626
6.
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.
J Am Acad Dermatol
; 88(6): 1308-1316, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36828138
7.
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
Eur Heart J
; 43(4): 280-299, 2022 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904661
8.
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib.
Nephrol Dial Transplant
; 37(3): 507-514, 2022 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33355659
9.
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque.
Circulation
; 142(24): 2299-2311, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33003973
10.
Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Oncologist
; 26(5): e898-e901, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33783099
11.
Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19.
Oncologist
; 26(8): 685-693, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33856099
12.
Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic Center.
Oncologist
; 26(8): e1427-e1433, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932247
13.
Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient Setting.
Oncologist
; 26(1): 49-55, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33044765
14.
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018.
Oncologist
; 26(6): 514-522, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33655682
15.
Case 1-2023: A 49-Year-Old Man with Hypokalemia and Paranoia.
N Engl J Med
; 388(2): 165-175, 2023 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36630625
16.
Liver biopsy findings in patients on immune checkpoint inhibitors.
Mod Pathol
; 34(2): 426-437, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32884128
17.
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.
Ann Neurol
; 87(5): 659-669, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32086972
18.
Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors.
Nephrol Dial Transplant
; 36(12): 2241-2247, 2021 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33374011
19.
Multi-detector computed tomography (MDCT)-based severity score as a prognostic tool in patients with suspected immune checkpoint inhibitor therapy associated colitis.
Eur Radiol
; 31(12): 8868-8878, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34081152
20.
Thermal Ablation, Embolization, and Selective Internal Radiation Therapy Combined with Checkpoint Inhibitor Cancer Immunotherapy: Safety Analysis.
J Vasc Interv Radiol
; 32(2): 187-195, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33353814